Karel Svoboda

Max Planck Florida Corporation

NIH Rank #1240
  • Program Leader
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$4.7M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#1,240
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $4.7M across 3 grants · National rank #1240.

Top grants by award amount

Karel Svoboda's NIH grant portfolio, ranked by award amount.

  • 1UM1MH136462-01UM1
    Optimization of genetically encoded voltage and neurotransmitter indicators for multiwavelength in vivo analysis of brain circuits
    $2.4M
    award amount
  • 5U01NS133760-02U01
    Neuropixels Opto: Integrated Silicon Probes for Cell-Type-Specific Electrophysiology
    $2.1M
    award amount
  • 5U19NS123714-03U19
    Thalamus in the middle: computations in multi-regional neural circuits
    $236.1K
    award amount

Affiliations

Institutions that have administered grants for Karel Svoboda.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Max Planck Florida Corporation
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1240
  6. 2024
    Entered Top 25% Nationally
    Ranked #1240
  7. 2024
    Entered Top 10% Nationally
    Ranked #1240
  8. 2024
    Multi-Institutional Research
    Awards at 2 institutions